Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Tolerability and Systemic Pharmacokinetics of AGN-232411 in Healthy Participants and Participants With Dry Eye

NCT02420730 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT02420730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02420730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Tolerability and Systemic Pharmacokinetics of AGN-232411 in Healthy Participants and Participants With Dry Eye
Lead sponsor
Allergan
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2015
Completion date
March 31, 2016
Enrollment
77 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye syndromes, healthy volunteers